Gonadotropin-releasing hormone antagonist

Results: 18



#Item
1ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

Add to Reading List

Source URL: www.ema.europa.eu

Language: English - Date: 2015-01-22 11:10:22
2IVF/GIFT Elonva® applications Purpose of this form Filling in this form

IVF/GIFT Elonva® applications Purpose of this form Filling in this form

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2014-09-09 22:04:37
3SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

Add to Reading List

Source URL: www.jogc.com

Language: English - Date: 2014-11-11 15:42:13
4SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

Add to Reading List

Source URL: www.jogc.ca

Language: English - Date: 2014-11-11 15:42:13
5SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

Add to Reading List

Source URL: jogc.com

Language: English - Date: 2014-11-11 15:42:13
6Microsoft Word - Oct[removed]updated report on OHSS for the HFEA by Adam Balen.doc

Microsoft Word - Oct[removed]updated report on OHSS for the HFEA by Adam Balen.doc

Add to Reading List

Source URL: www.hfea.gov.uk

Language: English - Date: 2014-12-17 05:38:44
7Final Report: Optimization and Clearance Studies of a New Hormone-Based Spawning Induction Technology for Aquacultured Finfish. Dr. Yonathan Zohar, University of Maryland Biotechnology Institute Grant Number: NA7bFD014S,

Final Report: Optimization and Clearance Studies of a New Hormone-Based Spawning Induction Technology for Aquacultured Finfish. Dr. Yonathan Zohar, University of Maryland Biotechnology Institute Grant Number: NA7bFD014S,

Add to Reading List

Source URL: www.nmfs.noaa.gov

Language: English - Date: 2005-01-12 10:42:33
8HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. TRELSTAR® (triptorelin pamoate for

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. TRELSTAR® (triptorelin pamoate for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-07-15 09:54:17
9Fertility / Leuprorelin / TAP Pharmaceuticals / Gonadotropin-releasing hormone agonist / In vitro fertilisation / Fertility medication / Endometriosis / Assisted reproductive technology / Gonadotropin-releasing hormone antagonist / Fertility medicine / Human reproduction / Medicine

DOC Document

Add to Reading List

Source URL: www.humanebiotech.com

Language: English - Date: 2014-09-21 02:19:17
10HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. These highlights do not include all

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. These highlights do not include all

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-03-15 15:20:35